| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S0950268813000332 |
| P698 | PubMed publication ID | 23472612 |
| P2093 | author name string | R Irwin | |
| S A McEwen | |||
| S Tamblyn | |||
| P Boerlin | |||
| F B Jamieson | |||
| R J Reid-Smith | |||
| C E Dewey | |||
| L Morrell | |||
| A E Deckert | |||
| P Seliske | |||
| P2860 | cites work | Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis | Q21144674 |
| Practice guidelines for the management of infectious diarrhea | Q30306770 | ||
| Loperamide-simethicone vs loperamide alone, simethicone alone, and placebo in the treatment of acute diarrhea with gas-related abdominal discomfort. A randomized controlled trial | Q33420630 | ||
| Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada | Q33698215 | ||
| Campylobacter jejuni Infections: update on emerging issues and trends | Q33941136 | ||
| Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates | Q34194136 | ||
| Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin | Q34394909 | ||
| Quinolone-resistant Campylobacter infections: risk factors and clinical consequences | Q35880423 | ||
| Antimicrobial resistance among Campylobacter strains, United States, 1997-2001. | Q35880517 | ||
| Fluoroquinolone resistance in campylobacter | Q37764099 | ||
| Clinical features of sporadic Campylobacter infections in Norway | Q40741442 | ||
| Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis | Q40846872 | ||
| A comparison of the in-vitro activity of clarithromycin, a new macrolide antibiotic, with erythromycin and other oral agents | Q43454251 | ||
| Human diseases caused by foodborne pathogens of animal origin | Q43978872 | ||
| Ciprofloxacin resistance in Campylobacter jejuni: case-case analysis as a tool for elucidating risks at home and abroad | Q44161004 | ||
| Double-blind placebo-controlled trial of erythromycin in the treatment of clinical campylobacter infection | Q44204629 | ||
| A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species | Q44990739 | ||
| Prolonged diarrhea due to ciprofloxacin-resistant campylobacter infection | Q45023861 | ||
| Economic burden from health losses due to foodborne illness in the United States. | Q45980309 | ||
| Short-term and medium-term clinical outcomes of quinolone-resistant Campylobacter infection. | Q46033434 | ||
| The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2010 | Q47151318 | ||
| Disease burden of post-infectious irritable bowel syndrome in The Netherlands | Q48864958 | ||
| Treatment of Acute Nonspecific Gastroenteritis of Infants and Young Children with Erythromycin | Q50211228 | ||
| Sporadic Campylobacter jejuni infections in Hawaii: associations with prior antibiotic use and commercially prepared chicken. | Q54017315 | ||
| Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. | Q54095870 | ||
| Comparison of antimicrobial resistance of Campylobacter jejuni isolated from humans, chickens, raw milk, and environmental water in Québec | Q80046422 | ||
| Post-infectious irritable bowel syndrome | Q84345502 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 2536-2546 | |
| P577 | publication date | 2013-03-08 | |
| P1433 | published in | Epidemiology and Infection | Q5382708 |
| P1476 | title | Burden of illness and factors associated with duration of illness in clinical campylobacteriosis | |
| P478 | volume | 141 |
Search more.